Home LiteratureArticle Details
PMID: 7970699 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways.

Oncogene ·Vol. 9 ·No. 12 ·1994-12-00 ·Pages 3407-15

Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA

Abstract

WAF1/Cip1 was recently identified as the wild-type p53 target that appears to mediate the tumor suppressing effects of p53. We investigated the mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma (HBC) cells. Our results demonstrate that the HBC cells harboring wild-type p53 express 26-33-fold higher WAF1/Cip1 mRNA levels than the cells harboring mutant p53. The DNA damaging agent etoposide induced p53 accumulation only in cells harboring wild-type p53 yet it induced WAF1/Cip1 gene expression in cells carrying wild-type or mutant p53, suggesting the involvement of p53-dependent and independent signaling pathways in the regulation of WAF1/Cip1 gene expression. Serum starvation-induced growth arrest although not altering the endogenous p53 levels or its ability to transactivate the reporter gene, induced WAF1/Cip1 gene expression in cells carrying wild-type as well as mutant p53. These results further implicated the involvement of p53-independent signal transduction pathways in WAF1/Cip1 gene regulation. Our data also suggest that WAF1/Cip1 gene expression is tightly associated with cell cycle progression in cells containing either wild-type or mutant p53. WAF1/Cip1 expression was transiently induced in response to serum treatment and declined as the cells passed through the S-phase of the cell cycle. We thus provide evidence that the mechanisms of WAF1/Cip1 gene regulation involve p53-dependent and independent signaling pathways in HBC.

Related Genes
MeSH Terms
Breast Neoplasms/genetics Cell Cycle/genetics Cyclin-Dependent Kinase Inhibitor p21 Cyclins/genetics Down-Regulation Gene Expression Regulation, Neoplastic/genetics Humans Promoter Regions, Genetic Protein Kinase Inhibitors RNA, Messenger/genetics,metabolism Signal Transduction Tumor Cells, Cultured Tumor Suppressor Protein p53/genetics,physiology
Chemicals
CDKN1A protein, human Cyclin-Dependent Kinase Inhibitor p21 Cyclins Protein Kinase Inhibitors RNA, Messenger Tumor Suppressor Protein p53
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Sheikh M S
Department of Medicine, University of Maryland School of Medicine, Baltimore.
Li X S
Chen J C
Shao Z M
Ordonez J V
Fontana J A
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
1994-12-00
Pages
3407-15
Language
English
Region
England
NLM ID
8711562
Subset
IM
Grants
NCI NIH HHS · CA 63335 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com